Variation in pneumococcal invasiveness metrics is driven by serotype carriage duration and initial risk of disease

Benjamin J Metcalf1, Kristofer Wollein Waldetoft2, Bernard W Beall3

  • 1School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia; Center for Microbial Dynamics and Infection, Georgia Institute of Technology, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia.

Epidemics
|December 1, 2023
PubMed

Insights

This study reveals flaws in using invasive odds ratios (IOR) to measure Streptococcus pneumoniae invasiveness. Attack rates (AR) may be more reliable for public health decisions regarding disease risk from different serotypes.

Area of Science:

  • Epidemiology
  • Infectious Disease Modeling
  • Public Health Microbiology

Background:

  • Streptococcus pneumoniae causes invasive diseases like meningitis and pneumonia.
  • Identifying high-risk serotypes is crucial for public health management.
  • Current invasiveness metrics include invasive odds ratios (IOR) and attack rates (AR).

Purpose of the Study:

  • To assess the reliability of IOR and AR metrics for estimating Streptococcus pneumoniae invasiveness.
  • To develop an epidemiological model of carriage and invasive disease to evaluate metric performance.
  • To identify potential biases in invasiveness estimations using IOR.

Main Methods:

  • Developed a mathematical epidemiological model for S. pneumoniae carriage and invasive disease.
  • Analyzed model behavior to identify metric failures, particularly with IOR.
  • Fitted the model to both longitudinal and cross-sectional data.

Main Results:

  • Mathematical analyses showed qualitative failures with the IOR metric, including declining values with increasing invasiveness.
  • Invasive disease risk is highest around the time of colonization.
  • IOR metrics can introduce substantial (up to 5-fold) biases in invasiveness estimation due to carriage duration.

Conclusions:

  • The IOR metric has significant limitations and raises concerns for public health decision-making.
  • Alternate metrics, such as attack rates (AR), are supported by the findings.
  • Accurate assessment of serotype invasiveness is critical for effective public health strategies against S. pneumoniae.